PCHRG v. FDA, Agouron Pharmaceuticals, et al.

Topic(s): 
Government Transparency — FOIA
Case Description: 

This action seeks the release of records concerning off-label, unapproved uses of previously approved drugs and biologics that drug companies submitted to the Food and Drug Administration for review. The case settled, granting access to the adverse event data which was sought (with redactions) and awarding attorneys fees.